Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antibiotic Use Increases Under Medicare Part D, Study Finds

This article was originally published in The Pink Sheet Daily

Executive Summary

Study published in AMA's Archives of Internal Medicine shows evidence of increased and sometimes inappropriate antibiotics use since the start of Medicare's prescription drug program.

You may also be interested in...



EHRs Could Help Address Antibiotic Overprescribing For Viral Respiratory Infections – Study

A recent study examining antibiotic prescribing patterns suggests that using electronic health records as a means of conveying surveillance data could help reduce the inappropriate use of antibiotics to treat viral respiratory infections.

Antibiotics Need REMS For Public, Not Patient, Safety Reasons, IDSA Says

Overuse of antibiotics could be controlled using elements of FDA’s Risk Evaluation and Mitigation Strategies, the Infectious Diseases Society of America argues in an upcoming position paper.

Antibiotics Need REMS For Public, Not Patient, Safety Reasons, IDSA Says

Overuse of antibiotics could be controlled using elements of FDA’s Risk Evaluation and Mitigation Strategies, the Infectious Diseases Society of America argues in an upcoming position paper.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel